Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Bodenmann et al. 2014 Switzerland | 250 patients with ≥5 ED visits in 12 months. Randomised to 125 in CM group (usual ED care + CM) and 125 in control group (usual ED care). Patients identified through ED tracking system. | RCT, 12-month follow-up (CM team delivering an assertive clinical CM model that involves a continuum of hospital- and community-based services) | ED attendances | This study reported a standardised regression coefficient of attendances: b. Both control and CM groups showed a significant reduction in the number of ED visits (b=-0.56, p<0.001), but the decrease was significantly more important for the intervention group (b=-0.025, p=0.012). | Selection bias: informed consent was obtained, 84 declined to participate. |
Reinius et al. 2013 Sweden | 268 patients with ≥3 ED visits in 6 months. Randomisation of 211 to CM group and 57 to control group; only 106 subsequently agreed to intervention. Patients extracted from electronic records according to attendances, followed by exclusion of certain populations, e.g. dementia, end-of-life and severe psychiatric disease. | Zelen’s design RCT, 12-month follow-up (Assignment of a CM nurse who designs care plans and makes intense weekly/biweekly phone contact with patients) | ED attendances | Moderate relative risk reduction in total number of ED visits (RR 0.77; 95% CI 0.69-0.86). | No absolute values quoted in results, only presented in events/person years. The study adopted the Zelen’s design whereby patients in the control group were not informed of the participation in the study. This raised problems with nonparticipation (significant when only 106 out of 211 in the participant group consented to intervention) especially when intention-to-treat principle was applied during analysis. It risks underestimating efficacy of the intervention and decreases overall validity. Selection bias: manual selection of patients who would more likely benefit from the intervention, requirement for informed consent and exclusion of certain populations. No attempt made at blinding, especially during data collection. |
Costs | Total costs per patient were 45% (p=0.004) lower in the intervention group. ED costs per patient were also 49% (p=0.09) lower. | ||||
Outpatients | Moderate relative risk reduction in total number of outpatient visits (RR 0.80; 95% CI 0.75-0.84). | ||||
Inpatient admissions | No significant decrease relative risk in the total number or ED hospital admissions. Total number of inpatient days lower in CM group due to shorter hospital stay. | ||||
Health status self-assessment | Significant increases (p<0.05) in 6 out of 8 parameters including general health perception, emotional role functioning, physical role functioning, bodily pain, social role functioning and vitality. | ||||
Shumway et al. 2008 United States | 252 patients divided into 2 groups: 5-11 ED visits and ≥12 ED visits in 12 months. Randomisation of 167 to CM group and 84 to control (usual ED care). Patients chosen by ED research assistants and case management supervisor; must have psychosocial problems addressable by CM to be eligible. | RCT, 24-month follow-up (Assignment of a psychiatric social worker who implements CM including crisis intervention, linkage to medical care providers and ongoing assertive community outreach to maintain continuity of care) | ED attendances | Statistically significant (p<0.01) difference in the mean number of ED visits between CM group (0.9 ± 1.5) and control (2.0 ± 3.4). Intervention is similarly effective for all levels of prior ED use (5-11 and ≥12). | No details of how randomisation was achieved. No mention of the change in the mean number of ED visits, both groups have different starting numbers. Selection bias: patients selected at discretion of ED staff and only between 8am – 5pm. Unavailability of case managers also means that some eligible patients would not be included. Potential for reporter bias in reporting psychosocial problems. No attempt at blinding, especially during data collection. |
Costs | Significantly lower ED costs (p<0.01) in CM group (247 ± 455) compared to controls (647 ± 1089). No difference in overall hospital costs. So cost-effective, but not cost-saving. | ||||
Outpatients | No significant difference in number of outpatient visits between CM and control group. | ||||
Inpatient admissions | Lower (p=0.08) mean number of hospital admissions in CM group, but no difference in use of other healthcare services. | ||||
Psychosocial factors | Statistically significant reduction in levels of homelessness, problem alcohol use, lack of health insurance and lack of social security income in CM group (p<0.05). | ||||
Spillane et al. 1997 United States | 70 patients with >10 ED visits in 12 months. Randomisation of 33 to intervention group and 37 to control group; only 25 and 27 patients respectively were evaluated. Patients extracted from electronic records according to attendances. | RCT, 12-month follow-up (Individual ED care plans on hospital system to guide appropriate medical and social management and CM to coordinate hospital- and community-based care) | ED attendances | No significant difference in the median number of ED visits between intervention and control groups (7 and 6 respectively). Median number of visits decreased by 7 in both groups. | Small sample size. Did not apply intention-to-treat principle. No information (e.g. timing within the study period) about patient deaths or attempt to correct for it during data analysis. Missing records, only 62% of individual ED visits were available for review. No mention of blinding especially of data analysers. |
Murphy and Neven 2014 United States | 144 patients divided into frequent users: 3-11 ED visits in 12 months, and extreme users: ≥12 ED visits in 12 months. Patients enrolled through ED staff referrals and Medicaid care plans. | Pre-post intervention study, 12-month follow-up (Individual ED care plans on hospital system to guide appropriate medical and social management which is shared with all EDs in the region and coordinating hospital- and community-based care, especially primary care) | ED attendances | Extreme group: median number of ED visits decreased by 79%. Frequent group: median number of ED visits decreased by 71%. | No control group or randomisation, but used statistical analysis to correct for regression to the mean. No mention of patient number in each group. Selection bias: patients were referred at the discretion of ED staff and Medicaid care plans. Preference of enrolment was also given to managed-care Medicaid patients. No mention of proportion of ED referrals to Medicaid patients or whether there were any overlaps. Not a concurrent study, patients were entered into the programme at different times within a 3-year period, introducing confounding. Unclear as to whether data was collected from regional EDs. |
Costs | Extreme group: 76% decrease in hospital treatment costs. Frequent group: 55% decrease in hospital treatment costs. Overall total direct costs were lower post-intervention, which also yielded a net income. | ||||
Shah et al. 2011 United States | 258 patients with ≥4 ED visits/≥3 inpatient admissions/≥2 admissions and 1 ED visit in 12 months. 98 received CM; 160 age- and ethnicity-matched controls Patients identified through monthly report based on attendances; must have low-income and be uninsured. | Pre-post intervention study, 18-month period (Assignment of a care manager who worked intensely with patients helping them to navigate primary care services, social care and third sector providers) | ED attendances | CM lowers the risk of ED visits by 32% when compared to the control group (Poisson regression reported to adjust for the covariates between groups). Unadjusted comparisons showed no difference between groups (p=0.8). | Retrospective design. No randomisation. Both groups were not matched for health status whereby the Charlson comorbidity index is significantly higher in the CM group. Selection bias: due to the nature of the program (i.e. a Medicaid demonstration project), biased towards the lower socioeconomic group. There was also selection due to informed consent. |
Costs | 26% reduction in ED costs and 65% reduction in inpatient admissions cost post-CM. None calculated for control group. | ||||
Inpatient admissions | No significant difference in risk of additional admissions in intervention group compared to controls (Poisson regression). Unadjusted comparisons showed no difference (p=0.7). |